Safety, Pharmacokinetics and Pharmacodynamics Study of Treatment With CHF 5074 in Healthy Young Male Subjects

Clinical trial NCT00954252 · COMPLETED

Trial details

NCT number: NCT00954252
Sponsor: CERESPIR
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2009-10-01
Primary completion: 2010-05-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.